Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Croatian heart failure registry - initial results (CROSBI ID 521595)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | domaća recenzija

Polić, Stojan ; Miličić, Davor ; Zaputović, Luka ; Glavaš, Duška Croatian heart failure registry - initial results // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora. 2006. str. 81-81

Podaci o odgovornosti

Polić, Stojan ; Miličić, Davor ; Zaputović, Luka ; Glavaš, Duška

engleski

Croatian heart failure registry - initial results

The aim of this internet-Registry is to collect and analyze information on HF pts in Croatia and to compare these data with the guidelines. The diagnosis and treatment may be refined to improve outcome in this patient population with high morbidity and mortality. Study population consisted of 100 HF pts hospitalized at cardiology departemtns in 3 hospitals: Split, Zagreb and Rijeka. The Registry analyzed "on line data" from September 2005 to February 2006. There were 61% of male and 39% of female pts, mean age 58.4 years. History of hypertension was recorded in 58.3%, diabetes comorbidity in 31.8%, and smoking habit in 38% of pts. Acute decompensation in chronic HF was diagnosed in 28% of pts, while 67.3% manifested as chronic HF. NYHA class II was recorded in 82% and NYHA class III in 7%, sinus rhythm in 34.2% and cardiomegaly (cardiothoracic ratio >0.33) in 63.3% of pts. Echocardiography was performed in 77.2% of study pts ; only 27% had LVEF <40%. BNP and proBNP tests were not performed in any of study pts. Diuretics (mainly loop diuretics) were presribed in 95% of pts, followed by beta blockers (68%), ACE inhibitors (56%), cardiac glycosides (39%), spironolactone (37%), AR antagonists (22%), antiarrhythmics (22%), oral nitrates (19%) and calcium channel blockers (9%). Daily dosage of ACE inhibitors and beta blockers was on an average below the recommended target dose. The initial results suggest the history of hypertension to predominate in our HF pts, while greater prescribing of the recommended medications such as ACE inhibitors rather than beta blockers remains limited and their daily dosage low.

heart failure; mortality; registry; predictors; treatment

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

81-81.

2006.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora

0024-3477

Podaci o skupu

14th Alpe Adria Cardiology Meeting & 1st International Congress of the Croatian Cardiac Society

predavanje

03.05.2006-07.05.2006

Cavtat, Hrvatska

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost